vaborbactam
Generic: vaborbactam·Brand: Vabomere
vaborbactam: 1 clinical trial tracked.
vaborbactam evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about vaborbactam, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Multi-Center, Open-Label, Single-Arm, Phase 2 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Vabomere (Meropenem-Vaborbactam) In The Treatment Of Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
Primary endpoint: Number of Participants With Adverse Events (AEs)
Interventionalopen66 targetStarted 2025-06Completion 2027-0726 sites · Bulgaria, Croatia, Georgia, Greece…Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)